earnings
saveAbbVie Inc. earnings
community read0 votes
Anticipated earnings call for AbbVie Inc. ($ABBV).
view source ↗Data sources
Found something off?
same company · ±60 days · 1
related news · 5
- biospaceAbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectations
- fiercebiotechAbbVie scratches out phase 3 hidradenitis suppurativa win but falls short of expectations
- biospaceAs AbbVie’s Crohn’s combo beats Skyrizi in mid-stage test, analysts laud autoimmune vision
- endpointsAbbVie’s Skyrizi combo beats Skyrizi alone in mid-stage Crohn’s trial
- fiercebiotechAbbVie’s next-gen Crohn’s disease combo beats Skyrizi in phase 2 trial
🐶 often sniffed alongside
top 8- tagApproval168 co-mentions · 84 sources
- drugHUMIRA122 co-mentions · 61 sources
- drugadalimumab122 co-mentions · 61 sources
- drugABRILADA61 co-mentions · 61 sources
- drugYUSIMRY61 co-mentions · 61 sources
- drugAMJEVITA61 co-mentions · 61 sources
- drugSKYRIZI46 co-mentions · 23 sources
- drugrisankizumab46 co-mentions · 23 sources
comments(0)
5-min edit window · permanent after that